School of Pharmacy

a girl working in a lab

Summer Undergraduate Researcher Mariam Zedan ’24 (PHARM)

The need for new antibiotics is crucial as drug-resistant strains of bacteria proliferate

To protect consumers, the FDA needs to strike a balance between quickly getting lifesaving drugs out to market and rigorously ensuring their safety.

The FDA’s Weak Drug Manufacturing Oversight is a Potentially Deadly Problem

The loss of tens of millions of COVID-19 vaccine doses due to poor manufacturing oversight underscores the value of inspections

UConn School of Pharmacy Pharmacy and Engineering Buildings

School of Pharmacy Earns Full 8 Year Continued ACPE Accreditation

The UConn School of Pharmacy is pleased to announce that its Doctor of Pharmacy Program (Pharm.D.)  has received a full eight-year accreditation by the Accreditation Council for Pharmacy Education (ACPE) Board of Directors.

A new drug has raised hopes for people with Alzheimer's disease, but the FDA has taken a major risk by approving it before comprehensive clinical trials have been conducted.

The FDA’s Big Gamble on a New Alzheimer’s Drug

No one knows yet if the new drug will demonstrate significant benefits for patients

UConn Researcher Receives $2 Million from NIH to Understand Role of Non-coding RNAs in Drug Metabolism

UConn researcher Xiaobo Zhong is studying how long non-coding RNAs influence the body's ability to metabolize drugs.

The UConn Health Pulse Podcast logo.

‘Urban Service Talks’ (About Interprofessional Learning)

The future physicians, dentists, nurses, social workers, pharmacists, and physician assistants who take part in the Connecticut Area Health Education Center's (CT AHEC) Urban Service Track/AHEC Scholars Program are walking the walk and now, talking the talk.

The sign in front of FDA headquarters in the Washington, D.C. area.

Why is the FDA Funded in Part by the Companies It Regulates?

Nearly half the agency's budget now comes from 'user fees' paid by companies seeking approval for medical devices or drugs

headshot of Dr. Andrew Agwunobi

UConn Health CEO Dr. Andrew Agwunobi Selected as University’s Interim President

UConn Health CEO Dr. Andrew Agwunobi will begin as UConn's Interim President beginning on July 1, 2021

Pharmacy Graduate Students Sweep 2021 AAPS-NERDG Awards

UConn School of Pharmacy graduate students took the top three places for their oral presentations at Academic Research Award in the AAPS Northeastern Regional Discussion Group (NERDG) Annual Meeting April 16, 2021: First prize – Karishma Dhuri, Dr. Raman Bahal Lab Dhuri’s research focuses on developing novel therapeutics for lymphoma therapy, combining nucleic acid chemistry and […]

young woman in medical face protection mask indoors on blue background.

Are Graphene-Coated Face Masks a COVID-19 Miracle – or Another Health Risk?

Balancing risk with uncertain rewards